Showing results (361-370 of 487) with videos related to

Sort By:
Pageof 49
JOP : Journal of the Pancreas|March 11, 2008
Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?Kyle T Elligers, Marianne Davies, Desiree Sanchis, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2006
Dihydropyrimidine dehydrogenase deficiency in an Indian populationMuhammad Wasif Saif, Lori Mattison, Tom Carollo, et al.
Heliyon|September 19, 2024
Examining ecological risks of metals in downstream river sediments: Researching agricultural carbon emission efficiency in environmental regulation perspectiveLi He, Liu Chang, Sansyzbaev Alisher Beibitovich, et al.
JOP : Journal of the Pancreas|September 28, 2020
Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9?Muhammad Wasif Saif, Melissa H Smith, Martin D Goodman, et al.
Annals of Gastroenterology|March 7, 2018
Post-transplantation lymphoproliferative disorder with gastrointestinal involvementFaisal Inayat, Ghias Ul Hassan, Ghias Un Nabi Tayyab, et al.
JOP : Journal of the Pancreas|March 13, 2014
Updates in management of ampullary carcinomasPreethi K John, Andromachi S Kougioumtzopoulou, Konstantinos N Syrigos, et al.
Cureus|April 28, 2020
Frequency of Left Ventricular Hypertrophy Among Patients on Maintenance Hemodialysis by Voltage Criteria and Its Relationship with Biophysical-Chemical ParametersAlvina Zanib, Shahid Anwar, Khurram Saleem, et al.
Cancer Chemotherapy and Pharmacology|December 26, 2016
Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1)Muhammad Wasif Saif, Andrew Heaton, Kimberley Lilischkis, et al.
Therapeutic Advances in Gastroenterology|September 2, 2015
Management of regorafenib-related toxicities: a reviewSaravanan K Krishnamoorthy, Valerie Relias, Sunit Sebastian, et al.
Therapeutic Advances in Gastroenterology|March 2, 2016
A novel schedule of erlotinib/capecitabine (7/7) as salvage therapy in previously treated advanced pancreatic adenocarcinoma: a case seriesJiezhong Chen, Kristin Kaley, Marie Carmel Garcon, et al.
Pageof 49